The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
390 - Do STI cards (cards that patients use to obtain medications for free or as a copay) come under PAAB or is this another industry organization that handles how these are used.
FYI post-approval change/preclearance exemption/what requires review/PAAB scope
1
Posts
1
Posters
338
Views
1
Watching
-
It’s the content on the card (or auxiliary pieces) that cause a piece to be exempt rather than the specific media. If the card only has the drug name, it is exempt per PAAB code s1.5. Images on the card could cause it not to be exempt. Also, linking the card to other content (which is typically the case) could cause the card to be non-exempt (e.g. if the linked materials exceeds PAAB code 1.5. for exemption).
